Kodiak Sciences Inc. 4

Victor Perlroth, Chairman and CEO of Kodiak Sciences Inc., received a stock option award for 100,000 shares at a $42.42 exercise price on July 15, 2026.

On July 15, 2026, Victor Perlroth, Chairman and CEO of Kodiak Sciences Inc., was granted a stock option to purchase 100,000 shares of the company’s common stock at an exercise price of $42.42 per share, expiring on July 14, 2036. The option vests over four years, with one forty-eighth of the shares vesting one month after July 1, 2026, and the remaining shares vesting in forty-seven equal monthly installments thereafter, contingent on his continued service. Following this equity award, he beneficially owns 100,000 shares (on an as-if-exercised basis) in a direct capacity, with an implied option award value of approximately $4.24 million based on the exercise price.

Filing Facts

CIK

1468748

Ticker

KOD

Form

4

Source Type

fda

Accession

0001754181-26-000011

Alert Tier

7